Literature DB >> 9670206

Role of cyclic adenosine monophosphate in reducing superoxide anion generation in guinea pig alveolar macrophages.

K Takei1, K Tokuyama, M Kato, A Morikawa.   

Abstract

Aveolar macrophages (AM) may contribute to airway inflammation via release of superoxide anion (O2-). Elevation of intracellular cyclic adenosine monophosphate (cAMP) levels has been shown to suppress O2- generation, although the exact mechanism is uncertain. To examine the inhibitory effect of cAMP against different stimuli for O2- generation, we compared the effect of cAMP on O2- generation caused by phorbol myristate acetate (PMA), a direct protein kinase C activator, and N-formyl-methionyl-leucyl-phenylalanine (FMLP), which couples its membrane receptor and stimulates guanosine triphosphate binding protein, in guinea pig AM. Cyclic nucleotide phosphodiesterase (PDE) isoenzyme inhibitors or CPT-cAMP, a cAMP analogue, were used in order to increase intracellular cAMP levels. The O2- generation caused by either PMA or FMLP was reduced by cilostazol (PDE 3 inhibitor) and Ro20-1724 (PDE 4 inhibitor), but not by zaprinast (PDE 5 inhibitor). The degree of reduction in O2- generation was not different between PMA and FMLP. Furthermore, CPT-cAMP also reduced PMA- or FMLP-induced O2- generation to a similar degree, although only high concentrations (10(-5) or 10(-4) mol/l) of this agent were effective in producing significant inhibition. A remarkable elevation of the cAMP level is required to produce the inhibitory effect on O2- generation in guinea pig AM. An elevation of cAMP may suppress O2- generation by inhibiting plural sites of the intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9670206     DOI: 10.1159/000028219

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

1.  Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patients.

Authors:  Shunji Shiohira; Takumi Yoshida; Hidekazu Sugiura; Satsuki Yoshida; Michihiro Mitobe; Katsunori Shimada; Takashi Ohba; Ken Tsuchiya; Takashi Kabaya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-07-20       Impact factor: 2.801

2.  Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage.

Authors:  Jack Hou; Anatol Manaenko; Jakob Hakon; Jacob Hansen-Schwartz; Jiping Tang; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

3.  Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells.

Authors:  Praveen Kumar; Nidhi Ahuja; Rakesh Bhatnagar
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

4.  Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the protein kinase A and exchange protein activated by cyclic AMP pathways.

Authors:  Linsey A Yeager; Ashok K Chopra; Johnny W Peterson
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

5.  Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia.

Authors:  Shinichiro Teramoto; Nobukazu Miyamoto; Kenji Yatomi; Yasutaka Tanaka; Hidenori Oishi; Hajime Arai; Nobutaka Hattori; Takao Urabe
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-13       Impact factor: 6.200

6.  The effect of selective phosphodiesterase inhibitors, alone and in combination, on a murine model of allergic asthma.

Authors:  Robert A Clayton; Colin A J Dick; Alison Mackenzie; Michiaki Nagasawa; Deirdre Galbraith; Stuart F Hastings; Simon J MacKenzie
Journal:  Respir Res       Date:  2004-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.